Four major drug manufacturers and a drug industry vendor recently urged a Washington D.C. federal court to reject the government [...] …
Category: Federal
Johnson & Johnson (J&J) added Ustekinumab, the unbranded version of psoriatic arthritis treatment Stelara, to its 340B contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Trump administration’s recent efforts to restructure the Department of Health and Human Services (HHS)—including division consolidations and the elimination [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Senate voted along party lines Thursday to confirm Mehmet Oz—a celebrity heart surgeon known as “Dr. Oz” for [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The leaders of a Senate panel that oversees several key federal health agencies this week invited Health and Human Services [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three drugmakers that have sued the federal government to convert 340B discounts to a rebate model, and a drug industry [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
340bVoice, the new advocacy arm of South Carolina-based health center Genesis Health Care, recently launched a five-figure, multi-state media campaign [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge yesterday delayed ruling on Sagebrush Health’s request for emergency relief after the government apparently reversed course and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In a sweeping overhaul of the nation’s top government health agencies, the U.S. Department of Health and Human Services (HHS) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The influential sponsor of a GOP U.S. House bill that would prohibit covered entities from using 340B savings on gender-affirming [...] …